Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Total knee AI/AR cleared for sales in the US

The FDA has granted 510(k) clearance to a French startup for surgery software that combines AI with augmented reality and computer vision.

9 healthcare outfits named among Forbes’s ‘top AI companies to watch’ in 2021

Forbes is out with its third annual AI 50, and almost a fifth of the field works in healthcare.

Medical AI company Caption Health appoints new CEO

Steve Cashman has been named CEO and president of the Brisbane, California-based organization, effective April 14.

GoodRx acquires healthcare video platform HealthiNation

GoodRx, an online source for healthcare savings and coupons, has closed its acquisition of HealthiNation, an online platform that offers thousands of videos with vital health information.

In face of COVID-19 pandemic, physician salaries remained largely unchanged

The analysis was based on data from nearly 18,000 physicians. 

1 new platform, 2 new companies sprout in Rochester, Minn.

Mayo Clinic has established a new AI-enabled tech platform and spawned two companies to leverage the might of its Big Data inputs.

FDA greenlights tabletop heart/lung sensor

A zero-contact health monitor about the size and shape of an external laptop speaker—one sure to fire the imagination of many a sci-fi fan—has won de novo clearance from the FDA.

Thumbnail

FDA approves first-of-its-kind colonoscopy AI

The FDA has granted de novo classification to an AI software module that puts a second pair of eyes on colonoscopy videos in real time and is compatible with any endoscope.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup